Literature DB >> 15917413

A population based seroepidemiological survey of Chlamydia pneumoniae infections in schoolchildren.

G Dal Molin1, B Longo, T Not, A Poli, C Campello.   

Abstract

AIM: A serosurvey was carried out in schoolchildren from a northeastern area of Italy to define the burden of Chlamydia pneumoniae infection.
METHODS: A sample of 649 schoolchildren underwent a simplified version of the International Study of Asthma and Allergies in Childhood questionnaire and IgG and IgA antibodies were investigated using an enzyme immunoassay, followed by a microimmunofluorescence assay in reactive sera.
RESULTS: Of the children examined, 29% and 19.7% had IgG and IgA antibodies, respectively. The IgG prevalence increased with age. No other sociodemographical variable was related to C pneumoniae infection. An association was established between IgA prevalence and previous otitis media.
CONCLUSIONS: A mesoendemic (intermediate between high and low endemic level) pattern of C pneumoniae infection is present in schoolchildren from this area and the prevalence rate is related to age. Moreover, this is the first epidemiological evidence of the role of C pneumoniae in otitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917413      PMCID: PMC1770689          DOI: 10.1136/jcp.2004.024380

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  29 in total

1.  Chlamydia pneumoniae in acute otitis media.

Authors:  S L Block; M R Hammerschlag; J Hedrick; R Tyler; A Smith; P Roblin; C Gaydos; D Pham; T C Quinn; R Palmer; J McCarty
Journal:  Pediatr Infect Dis J       Date:  1997-09       Impact factor: 2.129

2.  Asthma, atopy and Chlamydia pneumoniae antibodies in adults.

Authors:  L Von Hertzen; M Töyrylä; A Gimishanov; A Bloigu; M Leinonen; P Saikku; T Haahtela
Journal:  Clin Exp Allergy       Date:  1999-04       Impact factor: 5.018

3.  Age specific prevalence of antibodies against Chlamydia pneumoniae in Iceland.

Authors:  S Einarsson; H K Sigurdsson; S D Magnusdottir; H Erlendsdottir; H Briem; S Gudmundsson
Journal:  Scand J Infect Dis       Date:  1994

4.  Antibody response to Chlamydia pneumoniae infection in children with respiratory illness.

Authors:  A Kutlin; P M Roblin; M R Hammerschlag
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

5.  Chlamydia pneumoniae in children with acute respiratory tract infections.

Authors:  E Normann; J Gnarpe; H Gnarpe; B Wettergren
Journal:  Acta Paediatr       Date:  1998-01       Impact factor: 2.299

6.  Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease.

Authors:  L von Hertzen; R Isoaho; M Leinonen; R Koskinen; P Laippala; M Töyrylä; S L Kivelä; P Saikku
Journal:  Int J Epidemiol       Date:  1996-06       Impact factor: 7.196

7.  Etiology and treatment of community-acquired pneumonia in ambulatory children.

Authors:  L Wubbel; L Muniz; A Ahmed; M Trujillo; C Carubelli; C McCoig; T Abramo; M Leinonen; G H McCracken
Journal:  Pediatr Infect Dis J       Date:  1999-02       Impact factor: 2.129

8.  Etiology of childhood pneumonia: serologic results of a prospective, population-based study.

Authors:  T Heiskanen-Kosma; M Korppi; C Jokinen; S Kurki; L Heiskanen; H Juvonen; S Kallinen; M Stén; A Tarkiainen; P R Rönnberg; M Kleemola; P H Mäkelä; M Leinonen
Journal:  Pediatr Infect Dis J       Date:  1998-11       Impact factor: 2.129

9.  Antibodies to Chlamydia pneumoniae in healthy children from Bari, south Italy.

Authors:  R Monno; G Di Bitonto; L Marcuccio; M Valenza; C Marcuccio
Journal:  New Microbiol       Date:  1998-07       Impact factor: 2.479

10.  Chlamydia pneumoniae in children attending day-care centers in Gävle, Sweden.

Authors:  E Normann; J Gnarpe; H Gnarpe; B Wettergren
Journal:  Pediatr Infect Dis J       Date:  1998-06       Impact factor: 2.129

View more
  1 in total

1.  Infections and vaccinations preceding childhood Guillain-Barré syndrome: a prospective study.

Authors:  Joachim Schessl; Birgit Luther; Janbernd Kirschner; Gottfried Mauff; Rudolf Korinthenberg
Journal:  Eur J Pediatr       Date:  2006-05-12       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.